Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study

A.H. Maitland-van der Zee; A. Lynch; E. Boerwinkle; D.K. Arnett; B.R. Davis; C. Leiendecker-Foster; C.E. Ford; J.H. Eckfeldt

Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study

A.H. Maitland-van der Zee, A. Lynch, E. Boerwinkle, D.K. Arnett, B.R. Davis, C. Leiendecker-Foster, C.E. Ford, J.H. Eckfeldt

Dep Farmaceutische wetenschappen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	651-656
Number of pages	6
Journal	Pharmacogenetics and Genomics
Volume	18
Publication status	Published - 2008

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

Maitland-van der Zee, A. H., Lynch, A., Boerwinkle, E., Arnett, D. K., Davis, B. R., Leiendecker-Foster, C., Ford, C. E., & Eckfeldt, J. H. (2008). Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. Pharmacogenetics and Genomics, 18, 651-656.

Maitland-van der Zee, A.H. ; Lynch, A. ; Boerwinkle, E. et al. / Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. In: Pharmacogenetics and Genomics. 2008 ; Vol. 18. pp. 651-656.

@article{0c7a58fcfce54fe3b701d01f758a362b,

title = "Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "{Maitland-van der Zee}, A.H. and A. Lynch and E. Boerwinkle and D.K. Arnett and B.R. Davis and C. Leiendecker-Foster and C.E. Ford and J.H. Eckfeldt",

year = "2008",

language = "Undefined/Unknown",

volume = "18",

pages = "651--656",

journal = "Pharmacogenetics and Genomics",

issn = "1744-6872",

publisher = "Lippincott Williams and Wilkins",

}

Maitland-van der Zee, AH, Lynch, A, Boerwinkle, E, Arnett, DK, Davis, BR, Leiendecker-Foster, C, Ford, CE & Eckfeldt, JH 2008, 'Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study', Pharmacogenetics and Genomics, vol. 18, pp. 651-656.

Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. / Maitland-van der Zee, A.H.; Lynch, A.; Boerwinkle, E. et al.
In: Pharmacogenetics and Genomics, Vol. 18, 2008, p. 651-656.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study

AU - Maitland-van der Zee, A.H.

AU - Lynch, A.

AU - Boerwinkle, E.

AU - Arnett, D.K.

AU - Davis, B.R.

AU - Leiendecker-Foster, C.

AU - Ford, C.E.

AU - Eckfeldt, J.H.

PY - 2008

Y1 - 2008

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1744-6872

VL - 18

SP - 651

EP - 656

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

ER -

Maitland-van der Zee AH, Lynch A, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C et al. Interactions between the single nucleotide polymorphisms in the homocycteine pathway (MTHFR 677>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study. Pharmacogenetics and Genomics. 2008;18:651-656.